Regulatory Affairs Syndicator

Regulatory Affairs Updates and Bulletins by Joe Schwoebel

  • Blog
  • Warning Letters
  • FDA Links
  • Resource
  • Register


« Amgen Gets Inquiry From SEC Related to Aranesp Study (Update2) - Bloomberg
Heart help via the Internet - Kansas City Star »

Avanir Pharmaceuticals summarizes outcome of FDA meeting on Zenvia NDA - SpiritIndia

Published by Google Inc. March 1st, 2007 in Google FDA News, Regulatory Affairs


SpiritIndia
Avanir Pharmaceuticals summarizes outcome of FDA meeting on Zenvia NDA
SpiritIndia, India - 8 hours ago
AVANIR Pharmaceuticals (NASDAQ:AVNR) announced the Company has met with US Food and Drug Administration (FDA) officials to address concerns expressed in the …
AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA PipelineReview.com (press release)
UPDATE 1-Avanir to seek approval for lower dosage of Zenvia Reuters
Avanir Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA PharmaLive.com (press release)
all 19 news articles

Search



Regulatory Affairs Syndicator is powered by WordPress 2.0.3 and K2 Beta Two r167 by Michael and Chris
RSS Entries and RSS Comments